Mutations in the Ras isoforms HRAS, KRAS, or NRAS occur in approximately 30% of human cancers, with KRAS mutations being the most prevalent occurring in over 90% of pancreatic cancers and 32% of lung cancers [1–4]. Here, KRAS is linked to lung carcinoma.